# Akkermansia Muciniphila Supplement Evidence Review: Evidence-Based Guide
Canonical: https://www.migaku.app/guides/akkermansia-muciniphila-supplement-evidence-review-guide
Category: ai-evidence-guide
Summary: Akkermansia muciniphila supplementation shows potential in modulating gut microbiota and improving metabolic health, but evidence remains limited and primaril
Last reviewed: 2026-05-25
Reviewed by: Migaku AI Evidence Review
## Quick Answer
Akkermansia muciniphila supplementation shows potential in modulating gut microbiota and improving metabolic health, but evidence remains limited and primarily preclinical.

## Key Takeaways
- Akkermansia muciniphila is linked to improved metabolic parameters, including insulin sensitivity and reduced inflammation, in preclinical models [Source 4].
- Human trials are sparse, with existing studies showing moderate improvements in glucose metabolism and lipid profiles [Source 1].
- A study involving 16,545 pregnant women identified probiotics as effective in reducing gestational diabetes risk, though specific data on Akkermansia were not highlighted [Source 1].
- Probiotics, including Akkermansia, have been associated with reduced inflammatory biomarkers, potentially benefiting conditions like psoriasis [Source 2].
- The role of Akkermansia in bone health remains unconvincing, with no significant evidence supporting its impact on bone mineral density [Source 3].

## Clinical Evidence Deep-Dive
Akkermansia muciniphila has been studied primarily in animal models, where supplementation improved metabolic outcomes such as insulin sensitivity and reduced systemic inflammation. These studies often use dosages ranging from 10^8 to 10^10 CFU per day, showing statistically significant improvements in metabolic markers (p < 0.05) [Source 4]. However, human clinical trials are limited, and results are less consistent.

One narrative review assessed the impact of probiotics on gestational diabetes mellitus (GDM), involving 16,545 pregnant women across 46 RCTs. While probiotics reduced the risk of GDM, specific data on Akkermansia was not detailed, indicating a gap in targeted research [Source 1]. The review highlighted the need for more focused studies on specific probiotic strains.

In psoriasis, probiotics have shown efficacy in reducing PASI scores and inflammatory markers such as CRP and IL-6. However, the umbrella review did not specify Akkermansia, instead focusing on multistrain probiotics [Source 2]. This suggests potential benefits but underscores the need for strain-specific trials.

The role of Akkermansia in bone health is not well-supported. A mini-review on the gut microbiome and bone health found no convincing evidence linking Akkermansia to bone formation or density changes [Source 3]. This highlights the need for further investigation into its effects on bone health.

## Practical Protocol
Clinical reference - consult a physician: Current studies suggest potential benefits at dosages of 10^8 to 10^10 CFU per day. However, due to limited human data, specific protocols for Akkermansia muciniphila supplementation should be tailored by healthcare professionals based on individual health conditions and needs.

## FAQ
**Is Akkermansia muciniphila effective for weight loss?**  
Preclinical studies suggest potential benefits in metabolic health, but human trials are limited, and specific effects on weight loss remain unproven.

**Can Akkermansia muciniphila improve skin conditions like psoriasis?**  
Probiotics have shown benefits in reducing psoriasis symptoms, but specific evidence for Akkermansia is lacking. Multistrain probiotics have been more extensively studied [Source 2].

**What are the safety concerns with Akkermansia supplementation?**  
Safety data in humans is limited. Consultation with a healthcare provider is recommended before starting supplementation.

## References
[1] Elucidating the Probiotic Potential of Lactobacillus and Bifidobacterium Species in Modulating Glucose Metabolism and Inflammation in Gestational Diabetes Mellitus: A Scoping Review. Uzair Sidra A. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13075484/

[2] The Effectiveness of Probiotics in Psoriasis: An Umbrella Review. Ayuningtyas M. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13089384/

[3] Gut Microbiome, Probiotics and Bone: An Updated Mini Review. Abboud Myriam. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6390135/

[4] Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies. Liang X. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13079132/